More Invex Therapeutics Ltd. news
Invex Therapeutics Ltd.ASX: IXC

Appendix 4E and Annual Report to shareholders

Aug 10, 2025 at 10:42 PM EDT · Issued by Invex Therapeutics Ltd.

Filed with ASX · Aug 10, 2025 at 10:42 PM EDT

On 6ix: 6ix.com/news/appendix-4e-and-annual-report-to-shareholders-60

Invex Therapeutics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Invex Therapeutics Ltd. on 6ix

Story so far

  • 4E and Annual Report to shareholdersAug 19, 2022

Earlier from Invex Therapeutics

  • Invex Receives $0.22m R&D Tax Rebate from UK GovernmentJan 19, 2025
  • Improved Neuronal Cell Survival in 3D Model of Alzheimer'sDec 15, 2024
  • Quarterly Activities Report and Appendix 4COct 7, 2024
  • Invex receives R&D Tax RebateJun 21, 2024
  • ATO Class Ruling Return of CapitalMar 20, 2024

Later from Invex Therapeutics

  • Trading HaltSep 23, 2025
  • Suspension from QuotationSep 25, 2025
  • Corporate UpdateSep 30, 2025
  • Response to ASX Price and Volume QuerySep 30, 2025
  • Pause in TradingNov 7, 2025
All Invex Therapeutics news releases↗

Follow Invex Therapeutics into a list and get an email when it puts out news.

Follow Invex Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer